Stem Cell Transplantation
Prognostic value of early post-SCT airflow decline determined
Published in Blood Weekly, May 13th, 2004
According to recent research from Seattle, the "clinical significance of early air flow decline after myeloablative allogeneic hematopoietic SCT is uncertain.
To rectify this, J.W. Chien and colleagues at the Fred Hutchinson "performed a retrospective cohort analysis to determine if airflow decline by day 100 is associated with later development of transplant-related airflow obstruction (AFO) and increased mortality risk.
"Overall, 750 (40%) patients had airflow decline by day 100," they wrote in the journal Bone Marrow...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-05-13)
More Articles from Blood Weekly
- Leukemia
Flourine compounds toxic to human leukemic cells - Lymphoma Therapy
CHOP-R therapy feasible during PBSC mobilization - Stem Cell Transplantation
DLIs can resolve post-SCT relapse of pure red cell aplasia - Stem Cell Transplantation
Nonmyeloablative conditioning lowers risk of post-SCT pulmonary complications - Acute Myeloid Leukemia
Genetic screening study identifies most aggressive adult leukemia strains - Anthrax Vaccine
Anthrax vaccine phase II trial begins - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
